Tag: Big Pharma
AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline
NORTH CHICAGO, Ill. and NEW YORK, Aug. 25, 2025 -- AbbVie and Gilgamesh Pharmaceuticals Inc. ("Gilgamesh") announced a definitive agreement under which AbbVie will...
J&J Investment of $2B Boosts US Drug Manufacturing Capacity
Johnson & Johnson, an industry leader known for its global healthcare innovation, unveiled plans to increase its presence in the state of North Carolina...
Lupin, Sandoz Collab to Commercialise Biosimilar Ranibizumab
Lupin partners with Sandoz Group AG to commercialise and market its biosimilar ranibizumab worldwide. The product will be commercialised in a number of markets,...
Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront
Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI inhibition pathway
Abelacimab is currently in...
Popular